Congo, Democratic Republic of the vs Mali: Confirmed cases of MDR-TB started treatment for MDR-TB
Congo, Democratic Republic of the
100.0%
in 2012
Mali
100.0%
in 2012
Congo, Democratic Republic of the rank
3rd
Mali rank
3rd
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Congo, Democratic Republic of the
- Mali
How they compare
Congo, Democratic Republic of the currently reports 100.0% against 100.0% in Mali, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2008 it was Mali ahead.
Congo, Democratic Republic of the ranks 3rd and Mali ranks 3rd of 54 countries.
Across the 2 decades both report, Congo, Democratic Republic of the averaged higher in 1 and Mali in 1.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 146.5% | 50.0% | 96.5% | Congo, Democratic Republic of the |
| 2010s | 84.0% | 100.0% | 16.0% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Congo, Democratic Republic of the or Mali?
- Congo, Democratic Republic of the, at 100.0% against 100.0% in Mali as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Congo, Democratic Republic of the and Mali?
- 0.0%, with Congo, Democratic Republic of the ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Mali?
- 5 years are reported by both, from 2008 to 2012.
- How do Congo, Democratic Republic of the and Mali rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Congo, Democratic Republic of the ranks 3rd and Mali ranks 3rd of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.